Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206315119> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4206315119 endingPage "10" @default.
- W4206315119 startingPage "7" @default.
- W4206315119 abstract "Objectives: Chronic spontaneous urticaria (CSU) is correlated with a high detrimental effect on the quality of life (QoL). Antihistamines are the first choice drugs in the management of CSU. QoL is important in the evaluation of the efficacy of antihistamines, as these are the most commonly used in CSU. Materials and Methods: In this comparative, three-arm study, patients with CSU were randomized to standard dose of either bilastine, fexofenadine, or levocetirizine for a period of 4 weeks. Patients were assessed for improvement in their QoL based on chronic urticaria QoL questionnaire (CU-Q2oL) questionnaire and urticaria activity score (UAS). Results: Fifty-eight CSU patients were randomized to bilastine ( n = 23), fexofenadine ( n = 18) and levocetrizine ( n = 17) groups. There was significant improvement in CU-Q2oL and UAS score in all the groups during study period. 83%, 72%, and 65% patients reported improvement in CU-Q2oL score in bilastine, fexofenadine, and levocetrizine group, respectively. Bilastine was associated with significant improvement in CU-Q2oL compared to fexofenadine and levocetrizine ( P < 0.05). Mean reduction in UAS score was 86%, 77%, and 68% in bilastine, fexofenadine and levocetrizine group respectively. The difference was statistically insignificant between the groups. The CU-Q2oL total score correlated more strongly (r = 0.62; P = 0.001) with the UAS7 in bilastine group than fexofenadine (r = 0.57; P = 0.01) and levocetrizine groups (r = 0.53; P = 0.02). Conclusion: The results of the study proved that, in CSU patients, QoL was improved significantly with bilastine as compared to fexofenadine and levocetirizine." @default.
- W4206315119 created "2022-01-25" @default.
- W4206315119 creator A5022394926 @default.
- W4206315119 creator A5032330467 @default.
- W4206315119 creator A5034545061 @default.
- W4206315119 creator A5041889759 @default.
- W4206315119 creator A5051710377 @default.
- W4206315119 creator A5061916902 @default.
- W4206315119 creator A5069436933 @default.
- W4206315119 creator A5070489582 @default.
- W4206315119 creator A5089535952 @default.
- W4206315119 date "2022-01-13" @default.
- W4206315119 modified "2023-10-05" @default.
- W4206315119 title "Comparative assessment of quality of life in chronic spontaneous urticaria receiving second generation anti histamines: A real world study" @default.
- W4206315119 cites W1748713341 @default.
- W4206315119 cites W2002479630 @default.
- W4206315119 cites W2007817444 @default.
- W4206315119 cites W2083426219 @default.
- W4206315119 cites W2084391694 @default.
- W4206315119 cites W2095233257 @default.
- W4206315119 cites W2124616677 @default.
- W4206315119 cites W2127951211 @default.
- W4206315119 cites W2146380285 @default.
- W4206315119 cites W2149389632 @default.
- W4206315119 cites W2754038113 @default.
- W4206315119 cites W2810953097 @default.
- W4206315119 cites W86738069 @default.
- W4206315119 doi "https://doi.org/10.25259/ijsa_2_2021" @default.
- W4206315119 hasPublicationYear "2022" @default.
- W4206315119 type Work @default.
- W4206315119 citedByCount "0" @default.
- W4206315119 crossrefType "journal-article" @default.
- W4206315119 hasAuthorship W4206315119A5022394926 @default.
- W4206315119 hasAuthorship W4206315119A5032330467 @default.
- W4206315119 hasAuthorship W4206315119A5034545061 @default.
- W4206315119 hasAuthorship W4206315119A5041889759 @default.
- W4206315119 hasAuthorship W4206315119A5051710377 @default.
- W4206315119 hasAuthorship W4206315119A5061916902 @default.
- W4206315119 hasAuthorship W4206315119A5069436933 @default.
- W4206315119 hasAuthorship W4206315119A5070489582 @default.
- W4206315119 hasAuthorship W4206315119A5089535952 @default.
- W4206315119 hasConcept C126322002 @default.
- W4206315119 hasConcept C159110408 @default.
- W4206315119 hasConcept C168563851 @default.
- W4206315119 hasConcept C2776711289 @default.
- W4206315119 hasConcept C2779951463 @default.
- W4206315119 hasConcept C2780920841 @default.
- W4206315119 hasConcept C3017745231 @default.
- W4206315119 hasConcept C71924100 @default.
- W4206315119 hasConcept C90924648 @default.
- W4206315119 hasConcept C98274493 @default.
- W4206315119 hasConceptScore W4206315119C126322002 @default.
- W4206315119 hasConceptScore W4206315119C159110408 @default.
- W4206315119 hasConceptScore W4206315119C168563851 @default.
- W4206315119 hasConceptScore W4206315119C2776711289 @default.
- W4206315119 hasConceptScore W4206315119C2779951463 @default.
- W4206315119 hasConceptScore W4206315119C2780920841 @default.
- W4206315119 hasConceptScore W4206315119C3017745231 @default.
- W4206315119 hasConceptScore W4206315119C71924100 @default.
- W4206315119 hasConceptScore W4206315119C90924648 @default.
- W4206315119 hasConceptScore W4206315119C98274493 @default.
- W4206315119 hasLocation W42063151191 @default.
- W4206315119 hasOpenAccess W4206315119 @default.
- W4206315119 hasPrimaryLocation W42063151191 @default.
- W4206315119 hasRelatedWork W2003774312 @default.
- W4206315119 hasRelatedWork W2088006425 @default.
- W4206315119 hasRelatedWork W2126059075 @default.
- W4206315119 hasRelatedWork W2431155178 @default.
- W4206315119 hasRelatedWork W2771163873 @default.
- W4206315119 hasRelatedWork W2914465837 @default.
- W4206315119 hasRelatedWork W3164325668 @default.
- W4206315119 hasRelatedWork W4206315119 @default.
- W4206315119 hasRelatedWork W4220681817 @default.
- W4206315119 hasRelatedWork W3101530726 @default.
- W4206315119 hasVolume "1" @default.
- W4206315119 isParatext "false" @default.
- W4206315119 isRetracted "false" @default.
- W4206315119 workType "article" @default.